Patil T - Search Results

1

Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunity.

Kleczko EK, Hinz TK, Nguyen TT, Gurule NJ, Navarro A, Le AT, Johnson AM, Kwak J, Polhac DI, Clambey ET, Weiser-Evans M, Merrick DT, Yang MC, Patil T, Schenk EL, Heasley LE, Nemenoff RA. Kleczko EK, et al. Among authors: patil t. NPJ Precis Oncol. 2023 Feb 4;7(1):15. doi: 10.1038/s41698-023-00355-2. NPJ Precis Oncol. 2023. PMID: 36739466 Free PMC article.

2

The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non-Small Cell Lung Cancer and Rate of Central Nervous System Progression on Crizotinib.

Patil T, Smith DE, Bunn PA, Aisner DL, Le AT, Hancock M, Purcell WT, Bowles DW, Camidge DR, Doebele RC. Patil T, et al. J Thorac Oncol. 2018 Nov;13(11):1717-1726. doi: 10.1016/j.jtho.2018.07.001. Epub 2018 Jul 5. J Thorac Oncol. 2018. PMID: 29981925 Free PMC article.

3

Clinicopathologic Characteristics, Treatment Outcomes, and Acquired Resistance Patterns of Atypical EGFR Mutations and HER2 Alterations in Stage IV Non-Small-Cell Lung Cancer.

Patil T, Mushtaq R, Marsh S, Azelby C, Pujara M, Davies KD, Aisner DL, Purcell WT, Schenk EL, Pacheco JM, Bunn PA, Camidge DR, Doebele RC. Patil T, et al. Clin Lung Cancer. 2020 May;21(3):e191-e204. doi: 10.1016/j.cllc.2019.11.008. Epub 2019 Nov 21. Clin Lung Cancer. 2020. PMID: 31859066 Free PMC article.

4

2020 Innovation-Based Optimism for Lung Cancer Outcomes.

Schenk EL, Patil T, Pacheco J, Bunn PA Jr. Schenk EL, et al. Among authors: patil t. Oncologist. 2021 Mar;26(3):e454-e472. doi: 10.1002/onco.13590. Epub 2020 Dec 20. Oncologist. 2021. PMID: 33179378 Free PMC article. Review.

5

A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer.

Gurule NJ, McCoach CE, Hinz TK, Merrick DT, Van Bokhoven A, Kim J, Patil T, Calhoun J, Nemenoff RA, Tan AC, Doebele RC, Heasley LE. Gurule NJ, et al. Among authors: patil t. NPJ Precis Oncol. 2021 May 17;5(1):41. doi: 10.1038/s41698-021-00181-4. NPJ Precis Oncol. 2021. PMID: 34001994 Free PMC article.

6

Evolution of MET and NRAS gene amplification as acquired resistance mechanisms in EGFR mutant NSCLC.

Peters TL, Patil T, Le AT, Davies KD, Brzeskiewicz PM, Nijmeh H, Bao L, Camidge DR, Aisner DL, Doebele RC. Peters TL, et al. Among authors: patil t. NPJ Precis Oncol. 2021 Oct 12;5(1):91. doi: 10.1038/s41698-021-00231-x. NPJ Precis Oncol. 2021. PMID: 34642436 Free PMC article.

7

CNS Downstaging: An Emerging Treatment Paradigm for Extensive Brain Metastases in Oncogene-Addicted Lung Cancer.

Langston J, Patil T, Ross Camidge D, Bunn PA, Schenk EL, Pacheco JM, Jurica J, Waxweiler TV, Kavanagh BD, Rusthoven CG. Langston J, et al. Among authors: patil t. Lung Cancer. 2023 Apr;178:103-107. doi: 10.1016/j.lungcan.2023.02.006. Epub 2023 Feb 8. Lung Cancer. 2023. PMID: 36809719

8

Exceptional response to lorlatinib and cabozantinib in ROS1-rearranged NSCLC with acquired F2004V and L2086F resistance.

Sakamoto M, Patil T. Sakamoto M, et al. Among authors: patil t. NPJ Precis Oncol. 2023 Jun 8;7(1):56. doi: 10.1038/s41698-023-00381-0. NPJ Precis Oncol. 2023. PMID: 37291202 Free PMC article.

9

The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC.

Patil T, Staley A, Nie Y, Sakamoto M, Stalker M, Jurica JM, Koehler K, Cass A, Kuykendall H, Schmitt E, Filar E, Reventaite E, Davies KD, Nijmeh H, Haag M, Yoder BA, Bunn PA, Schenk EL, Aisner DL, Iams WT, Marmarelis ME, Camidge DR. Patil T, et al. JTO Clin Res Rep. 2024 Jan 18;5(2):100637. doi: 10.1016/j.jtocrr.2024.100637. eCollection 2024 Feb. JTO Clin Res Rep. 2024. PMID: 38361741 Free PMC article.

10

The Role of Local Therapy for Oligo-Progressive Disease in Oncogene-Addicted Non-Small-Cell Lung Cancer.

Tsui DCC, Holt DE, Patil T, Staley A, Gao D, Kavanagh BD, Schenk EL, Rusthoven CG, Camidge DR. Tsui DCC, et al. Among authors: patil t. Adv Radiat Oncol. 2024 Apr 14;9(7):101516. doi: 10.1016/j.adro.2024.101516. eCollection 2024 Jul. Adv Radiat Oncol. 2024. PMID: 38868503 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

307 results

Search Page

Filters